Oligodendroglioma Latest Advances

Find the Latest Research About Oligodendroglioma

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 4653 publications

Role of Surrogate Immunohistochemistry Markers in CNS Tumors in the Era of Molecular Diagnostics With Recent Updates.

Role of Surrogate Immunohistochemistry Markers in CNS Tumors in the Era of Molecular Diagnostics With Recent Updates.

Journal: Advances in anatomic pathology

Published: April 09, 2026

Acid Ceramidase Inhibition Disrupts Ceramide Homeostasis and Induces Mitochondrial Apoptosis in IDH1-Mutant Oligodendroglioma.

Acid Ceramidase Inhibition Disrupts Ceramide Homeostasis and Induces Mitochondrial Apoptosis in IDH1-Mutant Oligodendroglioma.

Journal: Research square

Published: April 03, 2026

Prognostic Impact of Calcification, Corpus Callosum Invasion, and CDKN2A/B Hemizygous Deletion in Oligodendroglioma: A Single-center Retrospective Study.

Prognostic Impact of Calcification, Corpus Callosum Invasion, and CDKN2A/B Hemizygous Deletion in Oligodendroglioma: A Single-center Retrospective Study.

Journal: Neurologia medico-chirurgica

Published: March 11, 2026

Association of CDKN2A/B and MTAP deletions in adult-type diffuse gliomas.

Association of CDKN2A/B and MTAP deletions in adult-type diffuse gliomas.

Journal: Journal of neuropathology and experimental neurology

Published: March 09, 2026

[18F]FET-PET in dissecting low-grade oligodendrogliomas.

[18F]FET-PET in dissecting low-grade oligodendrogliomas.

Journal: Journal of neuro-oncology

Published: February 13, 2026

Traveling large distances for awake functional-based surgery of IDH-mutated grade 2 glioma: outcomes comparison between loco-regional versus international patients.

Traveling large distances for awake functional-based surgery of IDH-mutated grade 2 glioma: outcomes comparison between loco-regional versus international patients.

Journal: Journal of neuro-oncology

Published: February 03, 2026

Upfront Radiation Therapy Increases Severe Neurotoxicity Risk in Patients With Oligodendrogliomas.

Upfront Radiation Therapy Increases Severe Neurotoxicity Risk in Patients With Oligodendrogliomas.

Journal: Anticancer research

Published: January 30, 2026

The role of immunohistochemical CIC expression in oligodendrogliomas for recurrence risk stratification.

The role of immunohistochemical CIC expression in oligodendrogliomas for recurrence risk stratification.

Journal: Clinical neuropathology

Published: January 19, 2026

[⁶⁸Ga]Ga-PSMA PET/CT Suggested Tumor Recurrence in a Treated Oligodendroglioma.

[⁶⁸Ga]Ga-PSMA PET/CT Suggested Tumor Recurrence in a Treated Oligodendroglioma.

Journal: Revista espanola de medicina nuclear e imagen molecular

Published: January 15, 2026

Delta-like ligand 3 expression in isocitrate dehydrogenase-mutant and isocitrate dehydrogenase-wildtype glioma is largely retained at recurrence, supporting its potential as a therapeutic target.

Delta-like ligand 3 expression in isocitrate dehydrogenase-mutant and isocitrate dehydrogenase-wildtype glioma is largely retained at recurrence, supporting its potential as a therapeutic target.

Journal: Neuro-oncology advances

Published: January 13, 2026

Differential diagnosis of high-grade astrocytic gliomas based on CD44, SOX2, and CIRBP gene expression analysis

Differential diagnosis of high-grade astrocytic gliomas based on CD44, SOX2, and CIRBP gene expression analysis

Journal: Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko

Published: January 13, 2026

Reasons driving choice and clinical course of patients with CNS WHO grade 3 IDH mutant glioma receiving vorasidenib after surgery: a pilot experience.

Reasons driving choice and clinical course of patients with CNS WHO grade 3 IDH mutant glioma receiving vorasidenib after surgery: a pilot experience.

Journal: Journal of neuro-oncology

Published: January 08, 2026

Showing 1-12 of 4,653

Last Updated: 04/28/2026